These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2785517)
21. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine. Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642 [TBL] [Abstract][Full Text] [Related]
22. Collaborative study on a Guinea pig serological method for the assay of acellular pertussis vaccines. Winsnes R; Sesardic D; Daas A; Terao E; Behr-Gross ME Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):27-40. PubMed ID: 20144450 [TBL] [Abstract][Full Text] [Related]
23. Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis. Giuliano M; Mastrantonio P; Giammanco A; Piscitelli A; Salmaso S; Wassilak SG J Pediatr; 1998 Jun; 132(6):983-8. PubMed ID: 9627590 [TBL] [Abstract][Full Text] [Related]
24. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children. Sato Y; Sato H Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079 [TBL] [Abstract][Full Text] [Related]
25. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247 [TBL] [Abstract][Full Text] [Related]
26. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group. Cassone A; Ausiello CM; Urbani F; Lande R; Giuliano M; La Sala A; Piscitelli A; Salmaso S Arch Pediatr Adolesc Med; 1997 Mar; 151(3):283-9. PubMed ID: 9080938 [TBL] [Abstract][Full Text] [Related]
27. B-cell responses after intranasal vaccination with the novel attenuated Bordetella pertussis vaccine strain BPZE1 in a randomized phase I clinical trial. Jahnmatz M; Amu S; Ljungman M; Wehlin L; Chiodi F; Mielcarek N; Locht C; Thorstensson R Vaccine; 2014 Jun; 32(27):3350-6. PubMed ID: 24793938 [TBL] [Abstract][Full Text] [Related]
28. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976 [TBL] [Abstract][Full Text] [Related]
29. Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults. Di Tommaso A; Bartalini M; Peppoloni S; Podda A; Rappuoli R; De Magistris MT Vaccine; 1997 Aug; 15(11):1218-24. PubMed ID: 9286047 [TBL] [Abstract][Full Text] [Related]
30. In vitro stimulation of human lymphocytes by Bordetella Pertussis. Andersen V; Hertz JB; Sorensen SF; Baekgaard P; Christensen PE; Ramhoj W; Hansen GA; Wardlaw AC; Sato Y Acta Pathol Microbiol Scand C; 1977 Feb; 85(1):65-72. PubMed ID: 190855 [TBL] [Abstract][Full Text] [Related]
31. Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine. Berstad AK; Oftung F; Korsvold GE; Haugen IL; Froholm LO; Holst J; Haneberg B Vaccine; 2000 May; 18(22):2323-30. PubMed ID: 10738087 [TBL] [Abstract][Full Text] [Related]